These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 33940446)
1. Discovery and development of tumor glycolysis rate-limiting enzyme inhibitors. Sun X; Peng Y; Zhao J; Xie Z; Lei X; Tang G Bioorg Chem; 2021 Jul; 112():104891. PubMed ID: 33940446 [TBL] [Abstract][Full Text] [Related]
2. Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis. Zuo J; Tang J; Lu M; Zhou Z; Li Y; Tian H; Liu E; Gao B; Liu T; Shao P Front Immunol; 2021; 12():779787. PubMed ID: 34899740 [TBL] [Abstract][Full Text] [Related]
3. Human steroid sulfatase enhances aerobic glycolysis through induction of HIF1α and glycolytic enzymes. Shin S; Kwon YJ; Ye DJ; Baek HS; Kwon TU; Kim D; Chun YJ Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2464-2474. PubMed ID: 31195119 [TBL] [Abstract][Full Text] [Related]
4. Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents. Sheng H; Tang W Recent Pat Anticancer Drug Discov; 2016; 11(3):297-308. PubMed ID: 27087655 [TBL] [Abstract][Full Text] [Related]
5. Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2. Chen J; Jiang Z; Wang B; Wang Y; Hu X Cancer Lett; 2012 Mar; 316(2):204-10. PubMed ID: 22154083 [TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase M2: A simple molecule with complex functions. Alquraishi M; Puckett DL; Alani DS; Humidat AS; Frankel VD; Donohoe DR; Whelan J; Bettaieb A Free Radic Biol Med; 2019 Nov; 143():176-192. PubMed ID: 31401304 [TBL] [Abstract][Full Text] [Related]
7. Effects of shRNA-Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells. Yan XL; Zhang XB; Ao R; Guan L J Cell Biochem; 2017 Dec; 118(12):4792-4803. PubMed ID: 28543190 [TBL] [Abstract][Full Text] [Related]
8. Interdependence of GLO I and PKM2 in the Metabolic shift to escape apoptosis in GLO I-dependent cancer cells. Shimada N; Takasawa R; Tanuma SI Arch Biochem Biophys; 2018 Jan; 638():1-7. PubMed ID: 29225125 [TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis. Gao P; Shen S; Li X; Liu D; Meng Y; Liu Y; Zhu Y; Zhang J; Luo P; Gu L Drug Des Devel Ther; 2020; 14():2091-2100. PubMed ID: 32546972 [TBL] [Abstract][Full Text] [Related]
10. Action at a distance: allostery and the development of drugs to target cancer cell metabolism. DeLaBarre B; Hurov J; Cianchetta G; Murray S; Dang L Chem Biol; 2014 Sep; 21(9):1143-61. PubMed ID: 25237859 [TBL] [Abstract][Full Text] [Related]
11. Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms. Liu J; Wu N; Ma L; Liu M; Liu G; Zhang Y; Lin X PLoS One; 2014; 9(3):e91606. PubMed ID: 24626155 [TBL] [Abstract][Full Text] [Related]
12. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis. Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609 [TBL] [Abstract][Full Text] [Related]
13. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells. Fukushi A; Kim HD; Chang YC; Kim CH Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431 [TBL] [Abstract][Full Text] [Related]
14. Follow the ATP: tumor energy production: a perspective. Oronsky BT; Oronsky N; Fanger GR; Parker CW; Caroen SZ; Lybeck M; Scicinski JJ Anticancer Agents Med Chem; 2014; 14(9):1187-98. PubMed ID: 25102360 [TBL] [Abstract][Full Text] [Related]
15. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs. Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959 [TBL] [Abstract][Full Text] [Related]
16. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment. Zhou Y; Huang Z; Su J; Li J; Zhao S; Wu L; Zhang J; He Y; Zhang G; Tao J; Zhou J; Chen X; Peng C Int J Cancer; 2020 Jul; 147(1):139-151. PubMed ID: 31652354 [TBL] [Abstract][Full Text] [Related]
17. Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment. Xintaropoulou C; Ward C; Wise A; Queckborner S; Turnbull A; Michie CO; Williams ARW; Rye T; Gourley C; Langdon SP BMC Cancer; 2018 Jun; 18(1):636. PubMed ID: 29866066 [TBL] [Abstract][Full Text] [Related]
18. Targeting Pyruvate Kinase M2 and Hexokinase II, Pachymic Acid Impairs Glucose Metabolism and Induces Mitochondrial Apoptosis. Miao G; Han J; Zhang J; Wu Y; Tong G Biol Pharm Bull; 2019 Jan; 42(1):123-129. PubMed ID: 30381614 [TBL] [Abstract][Full Text] [Related]
19. Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far? Chhipa AS; Patel S Life Sci; 2021 Sep; 280():119694. PubMed ID: 34102192 [TBL] [Abstract][Full Text] [Related]
20. Phosphofructokinase: a mediator of glycolytic flux in cancer progression. Al Hasawi N; Alkandari MF; Luqmani YA Crit Rev Oncol Hematol; 2014 Dec; 92(3):312-21. PubMed ID: 24910089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]